Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
CARD On Other Exchanges
Symbol
Exchange
OTC US
OTC BB
All times are local (Market data is delayed by at least 15 minutes).

cardigant medical inc (CARD) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIGANT MEDICAL INC (CARD)

Related News

No related news articles were found.

cardigant medical inc (CARD) Related Businessweek News

No Related Businessweek News Found

cardigant medical inc (CARD) Details

Cardigant Medical, Inc., a development stage biotechnology company, focuses on the development of novel biologic compounds and methods for local delivery for the treatment of acute coronary syndromes, carotid stenosis, and aortic valve stenosis. It plans to treat atherosclerosis and plaque stabilization using systemic and local delivery of large molecule therapeutics based on high density lipoprotein targets. The company’s lead drug product is based on the AApoA-1 protein, which has a specific role in the metabolism of lipids. Cardigant Medical, Inc. was founded in 2009 and is headquartered in Manhattan Beach, California. As of October 20, 2014, Cardigant Medical, Inc. was acquired by Takung Art Co., Ltd.

1 Employees
Last Reported Date: 04/8/14
Founded in 2009

cardigant medical inc (CARD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cardigant medical inc (CARD) Key Developments

Cardigant Medical Inc. Announces Management Changes

On October 20, 2014, Mr. Jerett Creed, Mr. Lei Wang and Mr. Yong Li resigned from all officers and directors positions they held with the company due to personal reasons and Mr. Xiao Di was appointed as the Chief Executive Officer, Chief Financial Officer and the sole director of the company.

Cardigant Medical Inc. Amends Article of Certificate of Incorporation

Effective September 19, 2014, Cardigant Medical Inc. amended article 4 of its Certificate of Incorporation to increase the total number of shares of common stock, par value $0.001 per share, it is authorized to issue from 50,000,000 to 1,000,000,000.

Cardigant Medical Inc. Announces Executive Changes, Effective September 22, 2014

On September 22, 2014, effective as William Pinon and Scott Merz, PhD resigned from the Board of Directors of Cardigant Medical Inc. At the time of his resignation, Mr. Pinon was Chairman of the Board. Dr. Merz did not hold any positions other than director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CARD:US $0.00 USD 0.00

CARD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CARD.
View Industry Companies
 

Industry Analysis

CARD

Industry Average

Valuation CARD Industry Range
No financial data is available for CARD.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIGANT MEDICAL INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.